[HTML][HTML] Ferroptosis in Parkinson's disease: glia–neuron crosstalk

ZL Wang, L Yuan, W Li, JY Li - Trends in molecular medicine, 2022 - cell.com
Parkinson's disease (PD) is characterized by dopaminergic (DA) neuron loss and the
formation of cytoplasmic protein inclusions. Although the exact pathogenesis of PD is …

Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases

A Cuadrado, AI Rojo, G Wells, JD Hayes… - Nature reviews Drug …, 2019 - nature.com
The transcription factor NF-E2 p45-related factor 2 (NRF2; encoded by NFE2L2) and its
principal negative regulator, the E3 ligase adaptor Kelch-like ECH-associated protein 1 …

Reactive astrocytes acquire neuroprotective as well as deleterious signatures in response to Tau and Aß pathology

Z Jiwaji, SS Tiwari, RX Avilés-Reyes, M Hooley… - Nature …, 2022 - nature.com
Alzheimer's disease (AD) alters astrocytes, but the effect of Aß and Tau pathology is poorly
understood. TRAP-seq translatome analysis of astrocytes in APP/PS1 ß-amyloidopathy and …

Amino acid transporter SLC7A11/xCT at the crossroads of regulating redox homeostasis and nutrient dependency of cancer

P Koppula, Y Zhang, L Zhuang, B Gan - Cancer communications, 2018 - Springer
Cancer cells often upregulate nutrient transporters to fulfill their increased biosynthetic and
bioenergetic needs, and to maintain redox homeostasis. One nutrient transporter frequently …

Ischemia-triggered glutamate excitotoxicity from the perspective of glial cells

D Belov Kirdajova, J Kriska, J Tureckova… - Frontiers in cellular …, 2020 - frontiersin.org
A plethora of neurological disorders shares a final common deadly pathway known as
excitotoxicity. Among these disorders, ischemic injury is a prominent cause of death and …

Nrf2 in cancers: A double‐edged sword

S Wu, H Lu, Y Bai - Cancer medicine, 2019 - Wiley Online Library
Abstract The Nrf2/Keap1 pathway is an important signaling cascade responsible for the
resistance of oxidative damage induced by exogenous chemicals. It maintains the redox …

Nrf2: a dark horse in Alzheimer's disease treatment

A Osama, J Zhang, J Yao, X Yao, J Fang - Ageing research reviews, 2020 - Elsevier
Abstract Alzheimer's disease (AD), an age-dependent neurodegenerative disorder, is the
main cause of dementia. Common hallmarks of AD include the amyloid β-peptide (Aβ) …

Astrocyte activation in neurovascular damage and repair following ischaemic stroke

A Patabendige, A Singh, S Jenkins, J Sen… - International journal of …, 2021 - mdpi.com
Transient or permanent loss of tissue perfusion due to ischaemic stroke can lead to damage
to the neurovasculature, and disrupt brain homeostasis, causing long-term motor and …

The Keap1–Nrf2 pathway: promising therapeutic target to counteract ROS-mediated damage in cancers and neurodegenerative diseases

P Deshmukh, S Unni, G Krishnappa… - Biophysical reviews, 2017 - Springer
The overproduction of reactive oxygen species (ROS) generates oxidative stress in cells.
Oxidative stress results in various pathophysiological conditions, especially cancers and …

[HTML][HTML] Brain energy metabolism: focus on astrocyte-neuron metabolic cooperation

M Bélanger, I Allaman, PJ Magistretti - Cell metabolism, 2011 - cell.com
The energy requirements of the brain are very high, and tight regulatory mechanisms
operate to ensure adequate spatial and temporal delivery of energy substrates in register …